ArticlePloS one2026
Screening anticancer activity by Brine shrimp lethality test of extracts of Annona stenophylla (Engl. & Diels), Strophanthus petersianus (Klotzsch) and Synadenium glaucescens (Pax).
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer continues to be one of the main public health challenges, driving the search for new compounds with therapeutic potential. Medicinal plants represent a valuable promising source of bioactive metabolites, and the Brine Shrimp Lethality Test has been widely used as a preliminary tool to assess the toxicity of natural extracts, providing clues to their possible anticancer activity. In this study, the cytotoxicity of the extracts of Annona stenophylla (Engl. & Diels), Strophanthus petersianus (Klotzsch), and Synadenium glaucescens (Pax) was investigated using the BSLT as a first step in screening for potential anticancer compounds. The plant materials were harvested in Tanzania and air-dried in the shade, and ground. The extracts were prepared by total sequential solvent extraction using cold maceration, starting with ethyl acetate, followed by methanol. A total of 24 ethyl acetate and methanolic extracts were obtained from the leaves, stem bark, stem wood, root wood and root bark of the three plants studied. The toxicity of the extracts was assessed by exposing Artemia salina nauplii to different concentrations of the extracts, with mortality recorded after 24 h. The LC50 was determined to evaluate the toxicity of each extract. All the extracts from the three plants exhibited different degrees of toxicity, with A. stenophylla demonstrating the lowest LC50 values, indicating the highest toxicity. The methanolic extract of A. stenophylla's root wood exhibited the highest toxicity, producing a mortality rate of 99.44%, corresponding to an LC50 < 20 μg/mL. The observed toxicity suggests the presence of bioactive compounds with potential anticancer activities. The results support the potential of A. stenophylla, S. petersianus and S. glaucescens as sources of bioactive compounds with possible anticancer activity. Further studies, including phytochemical analysis and in vitro anticancer assays, are recommended to identify and characterize the active constituents responsible for the observed cytotoxic effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.